Yüklüyor......
Resistance to histone deacetylase inhibitors confers hypersensitivity to oncolytic reovirus therapy
Despite the promising antilymphoma activity of histone deacetylase (HDAC) inhibitors as a drug class, resistance is a significant clinical issue. Elucidating the molecular mechanisms driving HDAC inhibitor resistance and/or the specific targets that are altered in drug-resistant cells may facilitate...
Kaydedildi:
| Yayımlandı: | Blood Adv |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Hematology
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7594386/ https://ncbi.nlm.nih.gov/pubmed/33108458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002297 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|